Clinical Evidence 2030
Clin Pharmacol Ther
.
2025 Apr;117(4):884-886.
doi: 10.1002/cpt.3596.
Epub 2025 Feb 14.
Authors
Peter Arlett
1
,
Denise Umuhire
1
,
Patrice Verpillat
1
,
Paolo Foggi
2
,
Ulla Wändel Liminga
3
,
Bruno Sepodes
4
,
Marianne Lunzer
5
,
Brian Aylward
6
,
Spiros Vamvakas
1
,
Kit Roes
7
,
Frank Pétavy
1
,
Steffen Thirstrup
1
,
Maria Lamas
8
,
Emer Cooke
1
,
Karl Broich
9
Affiliations
1
European Medicines Agency, Amsterdam, The Netherlands.
2
Italian Medicines Agency, Rome, Italy.
3
Lakemedelsverket, Uppsala, Sweden.
4
Infarmed, Lisbon, Portugal.
5
Österreichische Agentur für Gesundheit und Ernährungssicherheit, Vienna, Austria.
6
Irish Health Products Regulatory Authority, Dublin, Ireland.
7
Radboud University Medical Center, Nijmegen, The Netherlands.
8
Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
9
Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.
PMID:
39949283
PMCID:
PMC11924165
DOI:
10.1002/cpt.3596
No abstract available